IRM Quebec

Québec, Quebec G1J5B9

0 studies enrolling now · 1 studies all time

What they study most

Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis

Studies at this site

• Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) — Completed